​Restore the heart.

Protect the brain.​​​

Protembis Successfully Closes $ 10 Million Series A Financing Round

ProtEmbo Deflects Embolic Material Away from the Brain During TAVR
ProtEmbo is the best-in-class system providing a simple, quick, reliable solution to reduce the risk of cerebrovascular events during transcatheter aortic valve replacement (TAVR).

Oct 26, 2018

21-24 May 2019

Paris, France
Palais des Congrès

The ProtEmbo Cerebral Protection System

Cerebrovascular Events During TAVR
Cerebrovascular events occur in nearly all transcatheter aortic valve replacements (i.e.TAVR). These are associated with cognitive decline, 2- to 4-fold risk of future stroke, more than 3-fold risk of mortality, and more than 2-fold risk of dementia. Clinical cerebrovascular event rates as high as 9.1% have been reported following TAVR.

Come and meet Protembis

Latest News

​Facts To Know About ProtEmbo
•  Simple, quick and reliable deployment
•  Low-profile access via left radial artery (6Fr guiding sheath)
•  Complete coverage of all 3 aortic side branches
•  Deflection of microparticles as tiny as 60 microns
•  Suitable for a wide variety of aortic arch anatomies
•  Heparin coating for optimal biocompatibility
•  Best access route: no interference with TAVR catheter or accessories

CAUTION: The ProtEmbo® Cerebral Protection System is approved for investigational use in Europe.    ​​

© 2018 Protembis GmbH, all rights reserved.

Imprint     Privacy